4//SEC Filing
Bazarko Daniel 4
Accession 0000899866-21-000055
CIK 0000899866other
Filed
Jul 15, 8:00 PM ET
Accepted
Jul 16, 4:49 PM ET
Size
6.7 KB
Accession
0000899866-21-000055
Insider Transaction Report
Form 4
Bazarko Daniel
SVP, Controller, CAO
Transactions
- Award
Common Stock, par value $.0001 per share
2021-07-14+11,060→ 49,559 total - Award
Common Stock, par value $.0001 per share
2021-07-14+10,648→ 60,207 total
Footnotes (2)
- [F1]On July 14, 2021 the Leadership and Compensation Committee certified that certain performance metrics under previously granted performance stock units were satisfied. These performance stock units were previously granted in February 2019 under the 2017 Stock Incentive Plan.
- [F2]On July 14, 2021 the Leadership and Compensation Committee certified that certain performance metrics under previously granted performance stock units were satisfied. These performance stock units were previously granted in February 2020 under the 2017 Stock Incentive Plan.
Documents
Issuer
ALEXION PHARMACEUTICALS, INC.
CIK 0000899866
Entity typeother
Related Parties
1- filerCIK 0001768214
Filing Metadata
- Form type
- 4
- Filed
- Jul 15, 8:00 PM ET
- Accepted
- Jul 16, 4:49 PM ET
- Size
- 6.7 KB